Skip to main content

Table 2 Top 10 most-funded rare diseases by NFSC

From: Analysis of Incentive Policies and Initiatives on Orphan Drug Development in China: Challenges, Reforms and Implications

No.

Rare disease

Total

Funding

(million yuan)

Total projects

Funding per project

(million yuan)

Percentage

(%)

1

Idiopathic Pulmonary fibrosis

40.30

95

4.24

11.32

2

Multiple Sclerosis

36.22

93

3.89

10.17

3

Generalized Myasthenia Gravis

34.77

73

4.76

9.77

4

Retinitis Pigmentosa

28.86

55

5.25

8.11

5

Amyotrophic Lateral Sclerosis

28.63

69

4.15

8.04

6

Hemophilia

16.45

43

3.83

4.62

7

Homocysteinemia

15.15

19

7.97

4.26

8

Neuromyelitis Optica

14.50

33

4.39

4.07

9

Progressive Muscular Dystrophy

9.57

16

5.98

2.69

10

Retinoblastoma

9.49

24

3.95

2.67